Higher Heart Risk Seen in Inflammatory Arthritis With IFG
-
By
April 28, 2025
-
3 min
-
1
Study of 13,905 patients with inflammatory arthritis.
-
2
Impaired fasting glucose or sulfonylureas linked to higher risk of major adverse cardiovascular events.
-
3
Elevated glucose levels associated with increased cardiovascular risks.
-
4
Importance of proactive glucose management highlighted.
-
5
Need for careful selection of antidiabetic treatments in this patient population.
-
6
Proactive glucose monitoring and early blood glucose control may play a crucial role in preventing cardiovascular disease among patients with inflammatory arthritis.
-
7
Emphasizing the need for proactive glucose management and antidiabetic treatments.
-
8
Limitations include lack of data on lifestyle risk factors.
-
A study of 13,905 patients with inflammatory arthritis revealed that those with impaired fasting glucose or using sulfonylureas may face a higher risk of major adverse cardiovascular events. Elevated glucose levels and certain diabetes medications were associated with increased cardiovascular risks, emphasizing the importance of proactive glucose management in patients with inflammatory arthritis.
-
1
Study of 13,905 patients with inflammatory arthritis.
-
2
Impaired fasting glucose or sulfonylureas linked to higher risk of major adverse cardiovascular events.
-
3
Elevated glucose levels associated with increased cardiovascular risks.
-
4
Importance of proactive glucose management highlighted.
-
5
Need for careful selection of antidiabetic treatments in this patient population.
-
6
Proactive glucose monitoring and early blood glucose control may play a crucial role in preventing cardiovascular disease among patients with inflammatory arthritis.
-
7
Emphasizing the need for proactive glucose management and antidiabetic treatments.
-
8
Limitations include lack of data on lifestyle risk factors.
Listen Tab content
